Spatial Genomics And Transcriptomics Market

Home Healthcare And Pharmaceutical Spatial Genomics And Transcriptomics Market

Spatial Genomics and Transcriptomics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Technique (Spatial Transcriptomics, Spatial Genomics Analysis); By Product Type (Instruments, Consumables, Software); By Application (Translational Research, Drug Discovery & Development); By End Use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published Date: May 2023
Report ID: BWC23393
Available Format: PDF
Page: 400

Report Overview

A growing demand for personalized medicine and targeted therapeutics, rising investments in R&D activities in genomics and transcriptomics, and growing adoption of spatial genomics and transcriptomics in drug discovery and development processes are projected to propel the expansion of the global spatial genomics and transcriptomics market during the forecast period between 2023 and 2029.

Global Spatial Genomics and Transcriptomics Market - Industry Trends & Forecast Report, 2029

The global spatial genomics and transcriptomics market size was estimated at USD 199.46 million in 2022. During the forecast period between 2023 and 2029, the size of global spatial genomics and transcriptomics market is projected to grow at a CAGR of 11.35% reaching a value of USD 420.67 million by 2029. Major growth drivers for global spatial genomics and transcriptomics market include increasing demand for advanced tools that can provide more precise and detailed information about gene expression and cellular interactions. The global spatial genomics and transcriptomics market is expected to further experience significant growth in the coming years, due to the increasing demand for precision medicine and personalized treatments. Also, advances in single-cell sequencing technologies and the development of new spatial profiling methods are expected to drive the growth in this market.

Spatial Genomics and Transcriptomics Market

Global Spatial Genomics and Transcriptomics Market – Overview

Global spatial genomics and transcriptomics market refers to the use of advanced technologies that enable the visualization and analysis of gene expression patterns within intact tissues or cells. Spatial genomics and transcriptomics technologies provide high-resolution spatial information on gene expression patterns, allowing researchers to better understand the cellular and molecular mechanisms underlying complex biological processes. These technologies are used in a wide range of applications, including drug discovery, biomarker identification, and disease diagnosis. The market encompasses various products and services related to spatial genomics and transcriptomics, including instruments, reagents, software, and services for data analysis and interpretation.

Global Spatial Genomics and Transcriptomics Market

Growth Drivers

Increasing Investments in R&D of Genomics and Transcriptomics

With the increasing demand for precision medicine and personalized treatments, there has been a growing focus on developing new and advanced technologies that can provide more precise and detailed information about gene expression and cellular interactions. This has led to a surge in investments in R&D activities in genomics and transcriptomics, with many biotech and pharmaceutical companies investing heavily in developing new spatial profiling methods and single-cell sequencing technologies. Additionally, government organizations and academic institutions are also investing in genomics and transcriptomics research to advance the understanding of complex diseases and develop new treatments. These investments are expected to drive the growth of the global spatial genomics and transcriptomics market by enabling the development of new and more advanced technologies, as well as facilitating the adoption of these technologies in various applications. As a result, the market is expected to experience significant growth in the coming years, with increasing adoption of spatial genomics and transcriptomics technologies in drug discovery, biomarker identification, and disease diagnosis.

Restraints

Limited Awareness about Benefits of the Technology among End Users and Healthcare Professionals

The limited awareness among end users and healthcare professionals about the benefits is anticipated to restrain the global spatial genomics and transcriptomics market. When the potential users of these technologies are not aware of their benefits, they may not seek out the technology or invest in it, which can limit the growth of the market.

Impact of COVID-19 on Global Spatial Genomics and Transcriptomics Market

The COVID-19 pandemic had a dual impact on the global spatial genomics and transcriptomics market. The pandemic created a greater sense of urgency around the need for advanced genomics research to help combat the virus and develop effective treatments and vaccines. It drove increased funding and investments in the genomics sector overall, which could have positive spill-over effects for spatial genomics and transcriptomics. However, the pandemic also disrupted research activities and supply chains, which impacted the market growth. Laboratories and research facilities were shut down or operated at reduced capacity due to social distancing measures, which has slowed down the pace of research and development. Additionally, supply chain disruptions led to delays in the delivery of research reagents and other materials, which has further slowed down research activities. However, the market has rebounded after the pandemic, primarily due to the growing recognition of the advantages offered by spatial genomics and transcriptomics, leading to a wider acceptance and adoption of this technology.

Global Spatial Genomics and Transcriptomics Market

Segmental Coverage

Global Spatial Genomics and Transcriptomics Market – By Technique

By technique, the global spatial genomics and transcriptomics market is bifurcated into Spatial Transcriptomics and Spatial Genomics Analysis segments. The spatial transcriptomics segment held a higher market share primarily due to its widespread adoption in comparison to spatial genomic methods for studying single cells at the transcriptomic level. The growth of this segment can also be attributed to the availability of automated sequencing techniques, such as the laser capture microdissection (LCM) method, which has enabled the meeting of the increasing demand for nucleic acid sequencing of biological samples or single cells. The need for automated, robust, and scalable library preparation solutions has increased with the rise in nucleic acid sequencing of single cells or specific biological specimens. Additionally, several unique sequencing workflows have been introduced to infer or maintain spatial information, driven by an increased understanding of tissue heterogeneity, contributing to the growth of this segment. The spatial arrangement of molecules in cells and tissue samples is crucial for biological research and clinical practice, making it a focus area for various entities in the genetics field. The adoption of spatial genomic tools has also been propelled by advancements in genome perturbation tools, such as the CRISPR/Cas9 system, which has further contributed to the growth of this segment.

Global Spatial Genomics and Transcriptomics Market

Global Spatial Genomics and Transcriptomics Market – By Product Type

Based on end use, global spatial genomics and transcriptomics market is divided into Instruments, Consumables, and Software segments. The consumables segment held the highest market share in 2022 primarily due to its coverage of products that are essential for running instruments across various stages of genome mapping, ranging from sample preparation to result derivation. The high product penetration, wide availability of products, frequent purchase of consumables, and increased usage of reagents and kits to run the instruments have been key drivers of revenue flow in this segment. The growth of this segment is also dependent on any new instrument development or upgrades to existing instruments, as this will require the development of required consumables. The software segment is expected to experience significant growth, driven by the increasing volume of genomic research studies, which has created the need for robust software solutions for data management and interpretation. This is expected to fuel the growth of the segment in the coming years. Moreover, companies are expanding their service offerings to remain competitive in the market.

Spatial Genomics and Transcriptomics Market Share

Global Spatial Genomics and Transcriptomics Market – By Application

Based on application, the global spatial genomics and transcriptomics market is bifurcated into Translational Research and Drug Discovery & Development segments. The translational research segment held a higher share in the global spatial genomics and transcriptomics market due to high demand for targeted therapies and personalized medicine. Spatial genomics and transcriptomics technologies offer a more profound understanding of cell spatial arrangements and interactions, making it possible to identify new drug targets and develop therapies. The increasing investment in translational research by governments and private organizations has also boosted this segment's growth. The integration of these technologies into the translational research pipeline has led to the development of new diagnostics, therapeutics, and prognostic tools, further driving the segment's growth.

Spatial Genomics and Transcriptomics Market Size

Global Spatial Genomics and Transcriptomics Market – By End Use

Based on end use, the global spatial genomics and transcriptomics market is divided into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic & Research Institutes segments. The academic & research institutes segment holds the highest share in the global spatial genomics and transcriptomics market. Academic & research institutes play a vital role in the advancement of basic scientific research in the genomics and transcriptomics fields, which are essential for the development of spatial genomics and transcriptomics technologies. Moreover, these institutes have access to skilled researchers, experts, and technicians who have the necessary expertise to operate and maintain the advanced equipment and instruments required for spatial genomics and transcriptomics research. Additionally, academic and research institutions have access to government funding, grants, and collaborations with industry partners, enabling them to undertake large-scale research projects and collaborations, thus driving the growth of this segment.

Global Spatial Genomics and Transcriptomics Market – By Region

The in-depth research report on the global spatial genomics and transcriptomics market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America holds the highest share in the global spatial genomics and transcriptomics market. The region has a well-established and advanced healthcare infrastructure, with leading research institutes, academic centers, and biotech companies involved in spatial genomics and transcriptomics research. Also, the region has a high adoption rate of new technologies and a high level of awareness among healthcare professionals and end users regarding the benefits of spatial genomics and transcriptomics. The presence of major market players and collaborations between academic institutions and industry players for research and development further drives the growth of this market in North America. The availability of government funding for R&D and increasing investments in genomics and transcriptomics research have contributed to the growth of the market in this region.

Competitive Landscape

Major players operating in global spatial genomics and transcriptomics market include 10x Genomics, Inc., NanoString Technologies, Inc., Fluidigm Corporation, Illumina, Inc., Spatial Transcriptomics AB, Akoya Biosciences, Inc., ReadCoor, Inc., Seven Bridges Genomics, Inc., Ultivue, Inc., S2 Genomics, Inc., Cartana AB, Zymo Research Corp., RareCyte, Inc., Bio-Techne Corporation, and Dolomite Bio Limited. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

In April 2022 - 10x Genomics, a United States-based biotechnology company, introduced two sample prep kits to expand access to single-cell research.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2022
	Base Year – 2022
	Estimated Year – 2023
	Forecast Period – 2023–2029
Facts Covered	Revenue in USD Million
Market Coverage	North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Product/ Service Segmentation	Technique, Product Type, Application, End Use, Region
Key Players	10x Genomics, Inc., NanoString Technologies, Inc., Fluidigm Corporation, Illumina, Inc., Spatial Transcriptomics AB, Akoya Biosciences, Inc., ReadCoor, Inc., Seven Bridges Genomics, Inc., Ultivue, Inc., S2 Genomics, Inc., Cartana AB, Zymo Research Corp., RareCyte, Inc., Bio-Techne Corporation, Dolomite Bio Limited

By Technique

Spatial Transcriptomics
Spatial Genomics Analysis

By Product Type

Instruments
Consumables
Software

By Application

Translational Research
Drug Discovery & Development

By End Use

Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutes

By Region

North America
Europe
Asia Pacific (APAC)
Latin America
Middle East and Africa (MEA)

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Executive Summary
Global Spatial Genomics and Transcriptomics Market Insights
1. Industry Value Chain Analysis
2. DROC Analysis
  1. Growth Drivers
    1. Growing demand for personalized medicine and targeted therapeutics
    2. Rising investments in research and development activities in genomics and transcriptomics
    3. Growing adoption of spatial genomics and transcriptomics in drug discovery and development processes
  2. Restraints
    1. Limited awareness among End Users and healthcare professionals about the benefits
    2. Limited availability of infrastructure and resources in developing countries
  3. Opportunities
    1. Development of new applications for spatial genomics and transcriptomics in non-invasive prenatal testing
    2. Collaborations and partnerships between research institutions, academia, and industry players
  4. Challenges
    1. Ethical and legal issues related to genomics and transcriptomics research and use
3. Technology Advancements/Recent Developments
4. Regulatory Framework
5. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Global Spatial Genomics and Transcriptomics Market Overview
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share and Forecast
  1. By Technique
    1. Spatial Transcriptomics
    2. Spatial Genomics Analysis
  2. By Product Type
    1. Instruments
    2. Consumables
    3. Software
  3. By Application
    1. Translational Research
    2. Drug Discovery & Development
  4. By End Use
    1. Pharmaceutical & Biotechnology Companies
    2. Contract Research Organizations
    3. Academic & Research Institutes
    4. Others
  5. By Region
    1. North America
    2. Europe
    3. Asia Pacific (APAC)
    4. Latin America (LATAM)
    5. Middle East and Africa (MEA)
North America Spatial Genomics and Transcriptomics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Technique
  2. By Product Type
  3. By Application
  4. By End Use
  5. By Country
    1. United States
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    2. Canada
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
Europe Spatial Genomics and Transcriptomics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Technique
  2. By Product Type
  3. By Application
  4. By End Use
  5. By Country
    1. Germany
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    2. United Kingdom
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    3. Italy
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    4. France
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    5. Spain
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    6. Belgium
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    7. Russia
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    8. The Netherlands
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    9. Rest of Europe
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
Asia-Pacific Spatial Genomics and Transcriptomics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Technique
  2. By Product Type
  3. By Application
  4. By End Use
  5. By Country
    1. China
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    2. India
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    3. Japan
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    4. South Korea
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    5. Australia & New Zealand
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    6. Indonesia
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    7. Malaysia
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    8. Singapore
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    9. Vietnam
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    10. Rest of APAC
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
Latin America Spatial Genomics and Transcriptomics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Technique
  2. By Product Type
  3. By Application
  4. By End Use
  5. By Country
    1. Brazil
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    2. Mexico
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    3. Argentina
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    4. Peru
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    5. Rest of LATAM
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
Middle East & Africa Spatial Genomics and Transcriptomics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Technique
  2. By Product Type
  3. By Application
  4. By End Use
  5. By Country
    1. Saudi Arabia
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    2. UAE
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    3. Qatar
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    4. Kuwait
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    5. South Africa
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    6. Nigeria
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    7. Algeria
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
    8. Rest of MEA
      1. By Technique
      2. By Product Type
      3. By Application
      4. By End Use
Competitive Landscape
1. List of Key Players and Their Offerings
2. Global Spatial Genomics and Transcriptomics Market Share Analysis, 2022
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
Impact of Covid-19 on Global Spatial Genomics and Transcriptomics Market
Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
1. 10x Genomics, Inc.
2. NanoString Technologies, Inc.
3. Fluidigm Corporation
4. Illumina, Inc.
5. Spatial Transcriptomics AB
6. Akoya Biosciences, Inc.
7. ReadCoor, Inc.
8. Seven Bridges Genomics, Inc.
9. Ultivue, Inc.
10. S2 Genomics, Inc.
11. Cartana AB
12. Zymo Research Corp.
13. RareCyte, Inc.
14. Bio-Techne Corporation
15. Dolomite Bio Limited
16. Other Prominent Players
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1 Global Spatial Genomics and Transcriptomics Segmentation

Figure 2 Global Spatial Genomics and Transcriptomics Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2022

Figure 4 Global Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 5 Global Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 6 Global Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 7 Global Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 8 Global Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 9 Global Spatial Genomics and Transcriptomics Market Share, By Region, By Value, 2019–2029

Figure 10 North America Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 11 North America Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 12 North America Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 13 North America Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 14 North America Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 15 North America Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Figure 16 United States Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 17 United States Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 18 United States Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 19 United States Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 20 United States Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 21 Canada Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 22 Canada Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 23 Canada Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 24 Canada Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 25 Canada Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 26 Europe Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 27 Europe Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 28 Europe Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 29 Europe Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 30 Europe Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 31 Europe Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Figure 32 Germany Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 33 Germany Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 34 Germany Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 35 Germany Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 36 Germany Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 37 United Kingdom Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 38 United Kingdom Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 39 United Kingdom Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 40 United Kingdom Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 41 United Kingdom Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 42 Italy Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 43 Italy Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 44 Italy Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 45 Italy Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 46 Italy Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 47 France Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 48 France Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 49 France Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 50 France Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 51 France Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 52 Spain Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 53 Spain Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 54 Spain Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 55 Spain Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 56 Spain Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 57 Belgium Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 58 Belgium Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 59 Belgium Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 60 Belgium Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 61 Belgium Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 62 Russia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 63 Russia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 64 Russia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 65 Russia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 66 Russia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 67 The Netherlands Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 68 The Netherlands Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 69 The Netherlands Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 70 The Netherlands Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 71 The Netherlands Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 72 Rest of Europe Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 73 Rest of Europe Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 74 Rest of Europe Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 75 Rest of Europe Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 76 Rest of Europe Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 77 Asia-Pacific Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 78 Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 79 Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 80 Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 81 Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 82 Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Figure 83 China Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 84 China Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 85 China Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 86 China Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 87 China Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 88 India Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 89 India Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 90 India Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 91 India Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 92 India Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 93 Japan Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 94 Japan Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 95 Japan Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 96 Japan Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 97 Japan Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 98 South Korea Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 99 South Korea Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 100 South Korea Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 101 South Korea Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 102 South Korea Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 103 Australia & New Zealand Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 104 Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 105 Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 106 Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 107 Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 108 Indonesia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 109 Indonesia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 110 Indonesia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 111 Indonesia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 112 Indonesia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 113 Malaysia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 114 Malaysia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 115 Malaysia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 116 Malaysia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 117 Malaysia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 118 Singapore Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 119 Singapore Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 120 Singapore Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 121 Singapore Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 122 Singapore Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 123 Vietnam Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 124 Vietnam Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 125 Vietnam Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 126 Vietnam Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 127 Vietnam Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 128 Rest of APAC Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 129 Rest of APAC Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 130 Rest of APAC Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 131 Rest of APAC Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 132 Rest of APAC Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 133 Latin America Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 134 Latin America Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 135 Latin America Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 136 Latin America Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 137 Latin America Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 138 Latin America Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Figure 139 Brazil Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 140 Brazil Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 141 Brazil Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 142 Brazil Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 143 Brazil Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 144 Mexico Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 145 Mexico Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 146 Mexico Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 147 Mexico Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 148 Mexico Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 149 Argentina Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 150 Argentina Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 151 Argentina Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 152 Argentina Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 153 Argentina Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 154 Peru Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 155 Peru Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 156 Peru Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 157 Peru Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 158 Peru Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 159 Rest of LATAM Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 160 Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 161 Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 162 Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 163 Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 164 Middle East & Africa Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 165 Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 166 Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 167 Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 168 Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 169 Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Figure 170 Saudi Arabia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 171 Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 172 Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 173 Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 174 Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 175 UAE Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 176 UAE Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 177 UAE Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 178 UAE Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 179 UAE Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 180 Qatar Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 181 Qatar Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 182 Qatar Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 183 Qatar Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 184 Qatar Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 185 Kuwait Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 186 Kuwait Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 187 Kuwait Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 188 Kuwait Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 189 Kuwait Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 190 South Africa Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 191 South Africa Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 192 South Africa Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 193 South Africa Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 194 South Africa Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 195 Nigeria Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 196 Nigeria Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 197 Nigeria Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 198 Nigeria Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 199 Nigeria Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 200 Algeria Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 201 Algeria Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 202 Algeria Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 203 Algeria Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 204 Algeria Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Figure 205 Rest of MEA Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Figure 206 Rest of MEA Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Figure 207 Rest of MEA Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Figure 208 Rest of MEA Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Figure 209 Rest of MEA Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

List of Tables

Table 1 Global Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 2 Global Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 3 Global Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 4 Global Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 5 Global Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 6 Global Spatial Genomics and Transcriptomics Market Share, By Region, By Value, 2019–2029

Table 7 North America Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 8 North America Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 9 North America Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 10 North America Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 11 North America Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 12 North America Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Table 13 United States Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 14 United States Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 15 United States Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 16 United States Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 17 United States Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 18 Canada Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 19 Canada Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 20 Canada Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 21 Canada Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 22 Canada Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 23 Europe Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 24 Europe Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 25 Europe Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 26 Europe Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 27 Europe Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 28 Europe Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Table 29 Germany Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 30 Germany Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 31 Germany Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 32 Germany Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 33 Germany Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 34 United Kingdom Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 35 United Kingdom Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 36 United Kingdom Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 37 United Kingdom Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 38 United Kingdom Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 39 Italy Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 40 Italy Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 41 Italy Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 42 Italy Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 43 Italy Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 44 France Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 45 France Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 46 France Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 47 France Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 48 France Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 49 Spain Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 50 Spain Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 51 Spain Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 52 Spain Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 53 Spain Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 54 Belgium Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 55 Belgium Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 56 Belgium Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 57 Belgium Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 58 Belgium Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 59 Russia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 60 Russia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 61 Russia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 62 Russia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 63 Russia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 64 The Netherlands Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 65 The Netherlands Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 66 The Netherlands Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 67 The Netherlands Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 68 The Netherlands Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 69 Rest of Europe Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 70 Rest of Europe Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 71 Rest of Europe Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 72 Rest of Europe Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 73 Rest of Europe Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 74 Asia-Pacific Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 75 Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 76 Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 77 Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 78 Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 79 Asia-Pacific Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Table 80 China Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 81 China Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 82 China Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 83 China Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 84 China Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 85 India Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 86 India Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 87 India Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 88 India Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 89 India Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 90 Japan Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 91 Japan Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 92 Japan Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 93 Japan Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 94 Japan Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 95 South Korea Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 96 South Korea Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 97 South Korea Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 98 South Korea Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 99 South Korea Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 100 Australia & New Zealand Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 101 Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 102 Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 103 Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 104 Australia & New Zealand Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 105 Indonesia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 106 Indonesia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 107 Indonesia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 108 Indonesia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 109 Indonesia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 110 Malaysia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 111 Malaysia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 112 Malaysia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 113 Malaysia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 114 Malaysia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 115 Singapore Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 116 Singapore Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 117 Singapore Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 118 Singapore Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 119 Singapore Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 120 Vietnam Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 121 Vietnam Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 122 Vietnam Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 123 Vietnam Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 124 Vietnam Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 125 Rest of APAC Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 126 Rest of APAC Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 127 Rest of APAC Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 128 Rest of APAC Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 129 Rest of APAC Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 130 Latin America Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 131 Latin America Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 132 Latin America Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 133 Latin America Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 134 Latin America Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 135 Latin America Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Table 136 Brazil Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 137 Brazil Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 138 Brazil Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 139 Brazil Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 140 Brazil Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 141 Mexico Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 142 Mexico Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 143 Mexico Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 144 Mexico Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 145 Mexico Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 146 Argentina Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 147 Argentina Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 148 Argentina Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 149 Argentina Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 150 Argentina Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 151 Peru Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 152 Peru Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 153 Peru Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 154 Peru Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 155 Peru Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 156 Rest of LATAM Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 157 Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 158 Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 159 Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 160 Rest of LATAM Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 161 Middle East & Africa Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 162 Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 163 Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 164 Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 165 Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 166 Middle East & Africa Spatial Genomics and Transcriptomics Market Share, By Country, By Value, 2019–2029

Table 167 Saudi Arabia Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 168 Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 169 Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 170 Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 171 Saudi Arabia Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 172 UAE Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 173 UAE Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 174 UAE Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 175 UAE Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 176 UAE Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 177 Qatar Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 178 Qatar Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 179 Qatar Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 180 Qatar Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 181 Qatar Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 182 Kuwait Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 183 Kuwait Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 184 Kuwait Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 185 Kuwait Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 186 Kuwait Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 187 South Africa Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 188 South Africa Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 189 South Africa Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 190 South Africa Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 191 South Africa Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 192 Nigeria Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 193 Nigeria Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 194 Nigeria Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 195 Nigeria Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 196 Nigeria Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 197 Algeria Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 198 Algeria Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 199 Algeria Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 200 Algeria Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 201 Algeria Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 202 Rest of MEA Spatial Genomics and Transcriptomics Market Size, By Value (USD Million), 2019–2029

Table 203 Rest of MEA Spatial Genomics and Transcriptomics Market Share, By Technique, By Value, 2019–2029

Table 204 Rest of MEA Spatial Genomics and Transcriptomics Market Share, By Product Type, By Value, 2019–2029

Table 205 Rest of MEA Spatial Genomics and Transcriptomics Market Share, By Application, By Value, 2019–2029

Table 206 Rest of MEA Spatial Genomics and Transcriptomics Market Share, By End Use, By Value, 2019–2029

Table 207 10x Genomics, Inc. Company Overview

Table 208 10x Genomics, Inc. Financial Overview

Table 209 NanoString Technologies, Inc. Company Overview

Table 210 NanoString Technologies, Inc. Financial Overview

Table 211 Fluidigm Corporation Company Overview

Table 212 Fluidigm Corporation Financial Overview

Table 213 Illumina, Inc. Company Overview

Table 214 Illumina, Inc. Financial Overview

Table 215 Spatial Transcriptomics AB Company Overview

Table 216 Spatial Transcriptomics AB Financial Overview

Table 217 Akoya Biosciences, Inc. Company Overview

Table 218 Akoya Biosciences, Inc. Financial Overview

Table 219 ReadCoor, Inc. Company Overview

Table 220 ReadCoor, Inc. Financial Overview

Table 221 Seven Bridges Genomics, Inc. Company Overview

Table 222 Seven Bridges Genomics, Inc. Financial Overview

Table 223 Ultivue, Inc. Company Overview

Table 224 Ultivue, Inc. Financial Overview

Table 225 S2 Genomics, Inc. Company Overview

Table 226 S2 Genomics, Inc. Financial Overview

Table 227 Cartana AB Company Overview

Table 228 Cartana AB Financial Overview

Table 229 Zymo Research Corp. Company Overview

Table 230 Zymo Research Corp. Financial Overview

Table 231 RareCyte, Inc. Company Overview

Table 232 RareCyte, Inc. Financial Overview

Table 233 Bio-Techne Corporation Company Overview

Table 234 Bio-Techne Corporation Financial Overview

Table 235 Dolomite Bio Limited Company Overview

Table 236 Dolomite Bio Limited Financial Overview

Market Segmentation

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. What are the major factors driving the growth of Global Spatial Genomics and Transcriptomics Market?

Ans: Major factors driving the growth of Global Spatial Genomics and Transcriptomics Market include growing demand for personalized medicine and targeted therapeutics, rising investments in research and development activities in genomics and transcriptomics, and growing adoption of spatial genomics and transcriptomics in drug discovery and development processes.

2. What is the current market size of Global Spatial Genomics and Transcriptomics Market?

Ans: Global Spatial Genomics and Transcriptomics Market size was estimated at USD 199.46 million in 2022.

3. Which segment accounts for a major market share in the Global Spatial Genomics and Transcriptomics Market by technique?

Ans: The spatial transcriptomics segment is expected to hold a higher market share in the Global Spatial Genomics and Transcriptomics Market by technique.

4. Which segment accounts for the highest market share in the Global Spatial Genomics and Transcriptomics Market by product type?

Ans: The consumables segment is expected to hold the highest market share in the Global Spatial Genomics and Transcriptomics Market by product type.

5. Name the key players in Global Spatial Genomics and Transcriptomics Market.

Ans: Key players in the Global Spatial Genomics and Transcriptomics Market include 10x Genomics, Inc., NanoString Technologies, Inc., Fluidigm Corporation, Illumina, Inc., Spatial Transcriptomics AB, Akoya Biosciences, Inc., ReadCoor, Inc., Seven Bridges Genomics, Inc., Ultivue, Inc., S2 Genomics, Inc., Cartana AB, Zymo Research Corp., RareCyte, Inc., Bio-Techne Corporation, and Dolomite Bio Limited.

PLACE AN ORDER

SINGLE USER LICENSE
$ 4850
GROUP LICENSE
$ 5750
ENTERPRISE LICENSE
$ 8150
EXCEL DATA PACK
$ 3250

Request for Sample

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.